Literature DB >> 18485311

Non-autonomous cell death in Parkinson's disease.

Ted M Dawson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18485311      PMCID： PMC4505358          DOI： 10.1016/S1474-4422(08)70099-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  7 in total

1.  Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; Thomas B Freeman; C Warren Olanow
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

2.  Therapeutic cloning in individual parkinsonian mice.

Authors:  Viviane Tabar; Mark Tomishima; Georgia Panagiotakos; Sayaka Wakayama; Jayanthi Menon; Bill Chan; Eiji Mizutani; George Al-Shamy; Hiroshi Ohta; Teruhiko Wakayama; Lorenz Studer
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

3.  Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.

Authors:  G T Liberatore; V Jackson-Lewis; S Vukosavic; A S Mandir; M Vila; W G McAuliffe; V L Dawson; T M Dawson; S Przedborski
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

4.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.

Authors:  J W Langston; L S Forno; J Tetrud; A G Reeves; J A Kaplan; D Karluk
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

Review 5.  The role of glial reaction and inflammation in Parkinson's disease.

Authors:  E C Hirsch; T Breidert; E Rousselet; S Hunot; A Hartmann; P P Michel
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

6.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.

Authors:  Jia-Yi Li; Elisabet Englund; Janice L Holton; Denis Soulet; Peter Hagell; Andrew J Lees; Tammaryn Lashley; Niall P Quinn; Stig Rehncrona; Anders Björklund; Håkan Widner; Tamas Revesz; Olle Lindvall; Patrik Brundin
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

7.  Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years.

Authors:  Ivar Mendez; Angel Viñuela; Arnar Astradsson; Karim Mukhida; Penelope Hallett; Harold Robertson; Travis Tierney; Renn Holness; Alain Dagher; John Q Trojanowski; Ole Isacson
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440
  7 in total
  8 in total

Review 1.  Intercellular (mis)communication in neurodegenerative disease.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

Review 2.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson's Disease.

Authors:  Suraj S Pradhan; Kirstie Salinas; Alexis C Garduno; Jenny U Johansson; Qian Wang; Amy Manning-Bog; Katrin I Andreasson
Journal:  J Neuroimmune Pharmacol       Date:  2016-10-12       Impact factor: 4.147

Review 4.  Genetic animal models of Parkinson's disease.

Authors:  Ted M Dawson; Han Seok Ko; Valina L Dawson
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

Review 5.  Pathways towards an effective immunotherapy for Parkinson's disease.

Authors:  Jessica A L Hutter-Saunders; Rodney Lee Mosley; Howard E Gendelman
Journal:  Expert Rev Neurother       Date:  2011-12       Impact factor: 4.618

6.  Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model.

Authors:  Soo Jeong Kim; Min Jeong Ryu; Jeongsu Han; Yunseon Jang; Min Joung Lee; Xianshu Ju; Ilhwan Ryu; Yu Lim Lee; Eungseok Oh; Woosuk Chung; Jun Young Heo; Gi Ryang Kweon
Journal:  Lab Invest       Date:  2019-05-01       Impact factor: 5.662

7.  Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis.

Authors:  Xue Zhang; Yiming Zhang; Rui Li; Lingpeng Zhu; Buqing Fu; Tianhua Yan
Journal:  Aging (Albany NY)       Date:  2020-05-19       Impact factor: 5.682

Review 8.  Immunotherapy for Parkinson's disease.

Authors:  Aaron D Schwab; Mackenzie J Thurston; Jatin Machhi; Katherine E Olson; Krista L Namminga; Howard E Gendelman; R Lee Mosley
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.